The mosaiques diagnostics GmbH, located in Hanover (Germany), was founded in 2002 and is today the world leader in proteomic diagnostics based on unique proprietary technology and analysis software. We utilize multi-dimensional Diagnostic polypeptide biomarker Patterns (DiaPat) derived from the fast and accurate analysis of almost 6000 polypeptide protein fragments main-ly in urine but also in other body fluids (e.g. bile fluid and cerebrospinal fluid) to define disease classifiers according to clinical standards.